• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Carbonhand is available for Veterans in the US

    8/29/23 3:03:00 AM ET
    $BIOS
    Blank Checks
    Finance
    Get the next $BIOS alert in real time by email

    Bioservo signs a Sales Agent agreement with Trivet Medical LLC for sales of Carbonhand to Hospitals, Clinics, and Medical Centers within the Veterans Health Administration and Department of Defense in the US. With the first Sales Agent in place, the grip-strengthening device Carbonhand is available for all US Veterans suffering from impaired hand function.

    KISTA, Sweden, Aug. 29, 2023 /PRNewswire/ -- Trivet Medical LLC is a specialized strategic sales and distribution LLC, highly focused on commercializing disruptive, best-in-class med-tech devices and technologies. Founded by Charles Coyle, Trivet Medical's mission is to develop underrepresented and underserved healthcare conditions through innovative technology within the Department of Defense, Veterans Health, and key US Healthcare Markets, Regionally and Nationally. The sales team and channel comprise of successful and seasoned industry executives who have served in sales leadership, sales management & and sales training roles. 

    "We are excited and pleased to represent Bioservo for the US launch within the Department of Defense Hospitals and Veteran's Health Institutions," says Charles Coyle, founder of Trivet Medical LLC, and continues, "Carbonhand is a smart, intuitive, and revolutionary aid that gives back power to people with impaired hand function. There is no greater honor than to be of service to a member of our US Armed Forces who has given sacrifice, sustained injury, loss, or hardship. We are proud to be part of a restorative solution that impacts everyday life for US Veterans."

    "Our initial focus in the US is to increase independence and quality of life for US Veterans with impaired hand function. The Veterans Health Administration includes the largest coordinated healthcare system in the United States and has 9 million individuals enrolled," says Petter Bäckgren, CEO, Bioservo Technologies. "Recently we announced the agreement with Veterans Health Solutions Service as a wholesale distributor, the Trivet Medial sales team now signed is the first to start to promote Carbonhand to Veteran's Health Institutions. We will continue to expand our sales channel within the Veterans Health Administration."

    For more information, please contact,

    Petter Bäckgren, CEO, Bioservo Technologies AB

    Phone: +468 21 17 10

    [email protected]

    Loren Wass, US Commercial Development, Bioservo Technologies AB

    Phone: +1 978 502 6330

    [email protected] 

    About Bioservo Technologies

    Bioservo Technologies AB (publ) is a world-leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health of workers and to improve the quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.



    FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.

    For more information, please visit www.bioservo.com

    The following files are available for download:

    https://news.cision.com/bioservo-technologies-ab--publ-/i/carbonhand-garage,c3210244

    Carbonhand Garage

     

    Cision View original content:https://www.prnewswire.com/news-releases/carbonhand-is-available-for-veterans-in-the-us-301912117.html

    SOURCE Bioservo Technologies AB (publ)

    Get the next $BIOS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BIOS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bioplus Sponsor Llc

    4 - BioPlus Acquisition Corp. (0001856653) (Issuer)

    6/12/23 9:17:36 PM ET
    $BIOS
    Blank Checks
    Finance

    $BIOS
    SEC Filings

    View All

    $BIOS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SEC Form 15-12G filed by BioPlus Acquisition Corp.

    15-12G - BioPlus Acquisition Corp. (0001856653) (Filer)

    10/16/23 4:15:07 PM ET
    $BIOS
    Blank Checks
    Finance

    SEC Form 25-NSE filed by BioPlus Acquisition Corp.

    25-NSE - BioPlus Acquisition Corp. (0001856653) (Subject)

    10/6/23 4:03:10 PM ET
    $BIOS
    Blank Checks
    Finance

    SEC Form RW filed by BioPlus Acquisition Corp.

    RW - BioPlus Acquisition Corp. (0001856653) (Filer)

    10/4/23 7:39:57 AM ET
    $BIOS
    Blank Checks
    Finance

    BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

    New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. ("BIOS" or the "Company") (NASDAQ:BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have mutually agreed to terminate their previously announced business combination agreement and plan of reorganization (the "Business Combination Agreement"), effective as of October 4, 2023 and (ii) it intends to liquidate as soon as practicable after October 4, 2023 and to return funds to holders of its Class A ordinary shares that were included in the units issued in the Company's initial public offering ("Public Shares"). The Business Combination Agreement was dated as of May 2, 2023. The pa

    10/4/23 7:30:00 AM ET
    $BIOS
    Blank Checks
    Finance

    Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

    EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. ("Avertix" or the "Company"), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation (dba BioPlus Acquisition Corp.) ("BIOS") (NASDAQ:BIOS), a special purpose acquisition company, announced today that the two companies have mutually agreed to terminate their proposed business combination. "While we were enthusiastic about the potential business combination with BIOS, we mutually agreed that the current market conditions are not co

    10/4/23 7:30:00 AM ET
    $BIOS
    Blank Checks
    Finance

    Carbonhand is available for Veterans in the US

    Bioservo signs a Sales Agent agreement with Trivet Medical LLC for sales of Carbonhand to Hospitals, Clinics, and Medical Centers within the Veterans Health Administration and Department of Defense in the US. With the first Sales Agent in place, the grip-strengthening device Carbonhand is available for all US Veterans suffering from impaired hand function. KISTA, Sweden, Aug. 29, 2023 /PRNewswire/ -- Trivet Medical LLC is a specialized strategic sales and distribution LLC, highly focused on commercializing disruptive, best-in-class med-tech devices and technologies. Founded by Charles Coyle, Trivet Medical's mission is to develop underrepresented and underserved healthcare conditions through

    8/29/23 3:03:00 AM ET
    $BIOS
    Blank Checks
    Finance

    $BIOS
    Financials

    Live finance-specific insights

    View All

    Purple Innovation Announces Cooperative Framework with Coliseum Capital

    Company to Welcome New Directors to Board Adam Gray to Serve as Board Chair Gary DiCamillo to Continue to Serve as Lead Independent Director Company Will Redeem Cumulative Voting Proportional Representation Preferred Linked Stock Purple Innovation, Inc. (NASDAQ:PRPL) ("Purple" or the "Company"), a comfort innovation company known for creating the "World's First No Pressure® Mattress," today announced that it has entered into a binding Memorandum of Understanding to establish a cooperative governance framework (the "Planned Cooperation Agreement") with Coliseum Capital Management, LLC (together with its managed funds and accounts, "Coliseum"), the largest stockholder of the Company o

    4/13/23 4:05:00 PM ET
    $ADES
    $BIOS
    $LAZY
    Major Chemicals
    Industrials
    Blank Checks
    Finance

    $BIOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

    SC 13G/A - BioPlus Acquisition Corp. (0001856653) (Subject)

    2/12/24 4:14:06 PM ET
    $BIOS
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

    SC 13G/A - BioPlus Acquisition Corp. (0001856653) (Subject)

    2/9/24 10:26:34 AM ET
    $BIOS
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

    SC 13G/A - BioPlus Acquisition Corp. (0001856653) (Subject)

    2/7/24 2:00:23 PM ET
    $BIOS
    Blank Checks
    Finance